Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 CD109 expression levels in malignant melanoma.

Literature DB >> 20034764

CD109 expression levels in malignant melanoma.

Yuichiro Ohshima, Ichiro Yajima, Mayuko Y Kumasaka, Takeshi Yanagishita, Daisuke Watanabe, Masahide Takahashi, Yuji Inoue, Hironobu Ihn, Yoshinari Matsumoto, Masashi Kato.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2010 PMID： 20034764 DOI： 10.1016/j.jdermsci.2009.11.004

Source DB: PubMed Journal: J Dermatol Sci ISSN： 0923-1811 Impact factor: 4.563

Keyword Cloud
Cited

× No keyword cloud information.

23 in total

1. Endoplasmic reticulum stress activates SRC, relocating chaperones to the cell surface where GRP78/CD109 blocks TGF-β signaling.

Authors: Yuan-Li Tsai; Dat P Ha; He Zhao; Anthony J Carlos; Shan Wei; Tsam Kiu Pun; Kaijin Wu; Ebrahim Zandi; Kevin Kelly; Amy S Lee
Journal: Proc Natl Acad Sci U S A Date: 2018-04-13 Impact factor: 11.205

2. Correlated expression levels of endothelin receptor B and Plexin C1 in melanoma.

Authors: Mayuko Y Kumasaka; Ichiro Yajima; Machiko Iida; Hiro Takahashi; Yuji Inoue; Satoshi Fukushima; Hironobu Ihn; Kozue Takeda; Yuji Naito; Toshikazu Yoshikawa; Masashi Kato
Journal: Am J Cancer Res Date: 2015-02-15 Impact factor: 6.166

3. An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis.

Authors: Piia-Riitta Karhemo; Suvi Ravela; Marko Laakso; Ilja Ritamo; Olga Tatti; Selina Mäkinen; Steve Goodison; Ulf-Håkan Stenman; Erkki Hölttä; Sampsa Hautaniemi; Leena Valmu; Kaisa Lehti; Pirjo Laakkonen
Journal: J Proteomics Date: 2012-07-17 Impact factor: 4.044

4. CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.

Authors: Maki Yokoyama; Masaaki Ichinoe; Sosei Okina; Yasutaka Sakurai; Norihiro Nakada; Nobuyuki Yanagisawa; Shi-Xu Jiang; Yoshiko Numata; Atsuko Umezawa; Koji Miyazaki; Masaaki Higashihara; Yoshiki Murakumo
Journal: Int J Hematol Date: 2016-12-28 Impact factor: 2.490

5. The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β.

Authors: Mikoto Tanabe; Kohei Hosokawa; Mai Anh Thi Nguyen; Noriharu Nakagawa; Kana Maruyama; Noriaki Tsuji; Ryota Urushihara; Luis Espinoza; Mahmoud I Elbadry; Md Mohiuddin; Takamasa Katagiri; Masanori Ono; Hiroshi Fujiwara; Kazuhisa Chonabayashi; Yoshinori Yoshida; Hirohito Yamazaki; Atsushi Hirao; Shinji Nakao
Journal: Leukemia Date: 2021-11-06 Impact factor: 11.528

CD109 expression levels in malignant melanoma.

1. Endoplasmic reticulum stress activates SRC, relocating chaperones to the cell surface where GRP78/CD109 blocks TGF-β signaling.

2. Correlated expression levels of endothelin receptor B and Plexin C1 in melanoma.

3. An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis.

4. CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.

5. The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β.

6. Association of down-regulation of CD109 expression with up-expression of Smad7 in pathogenesis of psoriasis.

7. CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.

8. CD109 is a potential target for triple-negative breast cancer.

9. Metastasis-associated cell surface oncoproteomics.

10. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts.